GHISLAINE MAXWELL For the Period 5/I/I I to 8/31/11 Account Summary Asset Allocation Beginning Ending Change Estimated Current Asset Allocation Market Value Market Value In Value Annual Income Allocation Equity Alternative Assets 410,049.00 447,642.00 37,593.00 16,932.50 21% 60,948.00 79,876.00 18,928.00 4% Cash 8 Fixed Income 1.564.396.30 1,528,235.17 (36.161.13) 67,580.63 75% Market Value Accruals $2,036,393.30 33,026.74 $2,066,763.17 29,617.91 $20,369.87 (3,408.83) $84,613.13 100% Market Value with Accruals $2,068,420.04 $2,086,371.08 $16,961.04 Portfolio Activity Current Period Value Year-to-Date Value Beginning Market Value 2,035,393.30 1,946,279.39 Contributions 16,850.61 16,850.61 Withdrawals & Fees (269.80) (1,288.81) Securities Transferred In 884,911.95 4,198,650.57 Secuntes Transferred Out (897,138.13) (4,538,111.43) Net Contributions/Withdrawals $4,354.63 ($323,879.06) Income & Distributions 7,461.34 19,876.99 Change In Investment Value 8,543.90 413,475.85 Ending Market Value $2,065,763.17 $2,065,753.17 Accruals 29617.91 29 817.91 Market Value with Accruals $2,086,371.09 $2,086,371.08 JP Morgan Agnew ASS Cana Pawl &worn. Page 2 of 22 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00048001 SDNY_GM_00317199 EFTA01520674